209
Views
9
CrossRef citations to date
0
Altmetric
Review

Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa

, , , , &
Pages 1931-1937 | Accepted 01 Jun 2007, Published online: 10 Jul 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hans C Ebbers, Michael Muenzberg & Huub Schellekens. (2012) The safety of switching between therapeutic proteins. Expert Opinion on Biological Therapy 12:11, pages 1473-1485.
Read now
Marie-Hélène Lafeuille, Robert A. Bailey, Francis Vekeman, R. Scott McKenzie & Patrick Lefebvre. (2012) Utilization and cost comparison of erythropoiesis-stimulating agents in inpatient and outpatient hospital settings. Journal of Medical Economics 15:2, pages 352-360.
Read now
Amit Sharma, Jerry Yee, Shravanthi R. Gandra, Irfan Khan & Jeffrey Petersen. (2010) Estimate of maintenance EPO to darbepoetin alfa dose conversion ratio in a hospital-based dialysis patient population. Current Medical Research and Opinion 26:11, pages 2679-2687.
Read now

Articles from other publishers (6)

Michio Kuwahara, Syoko Hasumi, Shintaro Mandai, Tomomi Tanaka, Satomi Shikuma, Wataru Akita, Yoshihiro Mori & Sei Sasaki. (2013) Effects of three kinds of erythropoiesis-stimulating agents on renal anemia in Japanese non-dialysis chronic kidney disease patients. Clinical and Experimental Nephrology 18:5, pages 755-762.
Crossref
Marie-Hélène Lafeuille, Robert A. Bailey, Francis Vekeman, Brett S. Kilpatrick, Mekré Senbetta, Catherine T. Piech & Patrick Lefebvre. (2010) Drug Utilization and Cost for Erythropoiesis-Stimulating Agents in a Long-Term Care Resident Population with Chronic Kidney Disease. The Consultant Pharmacist 25:8, pages 493-500.
Crossref
A. Sanz-Granda. (2009) Análisis probabilístico de minimización de costes de darbepoetin alfa frente a epoetina alfa en el tratamiento de la anemia secundaria a insuficiencia renal crónica. Valoración en la práctica clínica española. Farmacia Hospitalaria 33:4, pages 208-216.
Crossref
A. Sanz-Granda. (2009) Probabilistic cost-minimisation analysis of darbepoetin alpha versus epoetin alpha in treating anaemia secondary to chronic renal failure. Assessment in Spanish clinical practice. Farmacia Hospitalaria (English Edition) 33:4, pages 208-216.
Crossref
R. Ravasio, C. Cerra & P. Fratino. (2013) Analisi dei consumi e dei costi degli agenti stimolanti l’eritropoiesi nel trattamento dell’anemia nei pazienti con insufficienza renale cronicaEvaluation of dosages and costs associated with the use of erythropoietin receptor agonists in the treatment of anemia in patients with chronic kidney disease. PharmacoEconomics Italian Research Articles 10:3, pages 161-169.
Crossref
Sarah Tomasello. (2008) Anemia of Chronic Kidney Disease. Journal of Pharmacy Practice 21:3, pages 181-195.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.